Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Operating expenses:
Total research and development	$ 18,400	$ 14,628	$ 35,841	$ 27,813
Total general and administrative	4,479	5,542	8,600	10,578
Total operating expenses	22,879	20,170	44,441	38,391
Loss from operations	(22,879)	(20,170)	(44,441)	(38,391)
Other income (expense):
Interest income, net	1,690	2,801	3,625	5,753
Other expense, net	(16)	(17)	(21)	(18)
Total other income	1,674	2,784	3,604	5,735
Loss before provision (benefit) for income taxes	(21,205)	(17,386)	(40,837)	(32,656)
Provision (benefit) for income taxes	5	(16,173)	(2,191)	(16,173)
Net loss	(21,210)	(1,213)	(38,646)	(16,483)
Unrealized (loss) on available for sale investments, net of tax	(61)	(61)	(123)	(380)
Foreign currency translation (loss) gain	(2)	5	6	(28)
Total other comprehensive loss	(63)	(56)	(117)	(408)
Total comprehensive loss	$ (21,273)	$ (1,269)	$ (38,763)	$ (16,891)
Net loss per share - basic	$ (0.41)	$ (0.02)	$ (0.74)	$ (0.32)
Net loss per share - diluted	$ (0.41)	$ (0.02)	$ (0.74)	$ (0.32)
Weighted-average common shares outstanding - basic	52,010,827	51,478,751	51,981,607	51,462,307
Weighted-average common shares outstanding - diluted	52,010,827	51,478,751	51,981,607	51,462,307